Myoblast transplantation in monkeys: Control of immune response by FK506

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 6, 1996, Pages 687-697

  Kinoshita, I ^a   Roy, R ^a   Dugre F J ^a   Gravel, C ^b   Roy, B ^a   Goulet, M ^a   Asselin, I ^a   Tremblay, J P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

FK 506; Immunosuppression; Monkeys; Myoblast; Transplantation

Indexed keywords

TACROLIMUS;

ANIMAL CELL; ARTICLE; CELL TRANSPLANTATION; HEREDITARY SPINAL MUSCULAR ATROPHY; IMMUNE RESPONSE; MONKEY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL;

EID: 0029888081     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199606000-00002     Document Type: Article

References (57)

1. Law PK, Goodwin TG, Wang M. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle and Nerve 1988;11:525-33
2. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibers from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-79
3. Law PK, Goodwin TG, Li H-J, Ajamoughli G, Chen M. Myoblast transfer improves muscle genetics/structure/function and normalizes the behavior and life-span of dystrophic mice. Adv Exp Med Biol 1990;280:75-88
4. Partridge TA. Myoblast transfer: A possible therapy for inherited myopathies? Muscle and Nerve 1991;14:197-212
5. Huard J, Bouchard JP, Roy R, et al. Human myoblast transplantation: Preliminary results of 4 cases. Muscle and Nerve 1992;15: 550-60
6. Morgan JE, Partridge TA. Cell transplantation and gene therapy in muscular dystrophy. BioEssays 1992;14:641-45
7. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transpl 1993;2:99-112
8. Law PK, Goodwin TG, Fang Q, et al. Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplantation 1993:2:485-505
9. Kinoshita I, Vilquin JT, Gravel C, Roy R, Tremblay JP. Myoblast allotransplantation in primates. Muscle and Nerve 1995;18:1217-18
10. Law PK, Bertorini TE, Goodwin TG, et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990;336:114-15
11. Law PK, Goodwin TG, Fang Q, et al. Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplant 1992;1:235-44
12. Gussoni E, Pavlath GK, Lanctot AM, et al. Normal dystrophin transcripts detected in DMD patients after myoblast transplantation. Nature 1992;356:435-38
13. Karpati G, Ajdukovic D, Arnold D, et al. Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993;34:8-17
14. Mendell JR, Kissel JT, Amato AA et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Eng J Med 1995;333:832-38
15. Thompson L. Cell-transplant results under fire. Science 1992;257: 472-74
16. Law PK. Myoblast transplantation. Science 1992;257:1329
17. Furlong TE. Myoblast transplantation. Science 1992;257:1329
18. The Editors. Myoblast transplantation. Response. Science 1992;257: 1329-30
19. Guérette B, Asselin I, Vilquin JT, Roy R, Tremblay JP. Lymphocyte infiltration following allo and xeno myoblast transplantation in mdx mice. Muscle and Nerve 1994;18:39-51
20. Irintchev A, Zweyer M, Wernig A. Cellular and molecular reactions in mouse muscles after myoblast implantation. Journal of Neurocytology 1995;24:1-13
21. Guérette B, Roy R, Tremblay M, Asselin I, Kinoshita I, Tremblay JP. Increased granzyme B mRNA following alloincompatible myoblast transplantation. Transplantation 1995;60:1011-16
22. Guérette B, Tremblay G, Vilquin JT, et al. Increased interferon-gamma mRNA expression following alloincompatible myoblast transplantation is inhibited by FK506. Muscle and Nerve (in press)
23. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Quantitative studies of efficacy of myoblast transplantation. (Abstract) Muscle and Nerve 1994;Supp14:S261
24. Huard J, Acsadi A, Jani B, Massie B, Karpati G. Comparison of the efficiency of gene transfer by genetically marked co-isogenic myoblasts vs uncultured satellite cells in normal and mdx mouse muscles. Muscle and Nerve 1994;Suppl. 1:S261 (Abstract)
25. Tremblay JP, Bouchard JP, Malouin F, et al. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromusc Disord 1993;3:583-92
26. Watt DJ, Partridge TA, Sloper JG. Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice. Transplantation 1981;31:266-71
27. Watt DJ, Morgan JE, Partridge TA. Long-term survival of allografted muscle precursor following a limited period of treatment with cyclosporin A. Clin Exp Immunol 1984;55:419-26
28. Huard J, Roy R, Guérette B, Verreault S, Tremblay G, Tremblay JR Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle and Nerve 1994;17:224-34
29. Vilquin JT, Asselin I, Guérette B, et al. Myoblast allotransplantation in mice: The degree of success varies depending on the efficacy of various immunosuppressive treatments. Transpl Proc 1994;26: 3372-73
30. Pavlath GK, Rando TA, Blau HM. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol 1994;127:1923-32
31. Mendell JR. Immunosuppressive therapy in Duchenne muscular dystrophy: Considerations for myoblast transfer studies. Adv Exp Med Biol 1990;280:287-96
32. Vilquin JT, Asselin I, Guérette B, Kinoshita I, Roy R, Tremblay JP. Successful myoblast transplantation in mdx mice using rapamycin. Transplantation 1995;59:422-49
33. Kinoshita I, Vilquin J-T, Guérette B, Asselin I, Roy R, Tremblay JP. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle and Nerve 1994;17:1407-15
34. Vilquin JT, Kinoshita I, Roy R, Tremblay JP. Cyclophosphamide immunosuppression does not permit successful myoblast allotransplantation in mouse. Neuromusc Disord 1995;5:511-17
35. Yasin R, Beers V, Bullen D, Thompson EJ. A quantitative procedure for the dissociation of adult mammalian muscle into mononucleated cells. Exp Cell Res 1976;102:405-8
36. Ham RG, St. Clair JA, Meyer SD. Improved media for rapid clonal growth of normal human skeletal muscle satellite cells. Adv Exp Med Biol 1990;280:193-200
37. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-59
38. Zhao X-M, Yeoh T-K, Hiebert M, Frist WH, Miller GG. The expression of acidic tibroblast growth factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells. Transplantation 1993;56:1177-82
39. Lipman ML, Stevens AC, Bleackley RC, et al. The strong correlation of cytotoxic T lymphocyte specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992;53:73-79
40. Lagoo-Deenadayalan S, Lagoo AS, Barber WH, Hardy KJ. A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res 1993;12:59-67
41. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73
42. Alard MJ, Wood KJ, Hamano K et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993;133:5-18
43. Zhao X-M, Frist WH, Yeoh T-K, Miller GG. Expression of cytokine genes in human cardiac allografts: Correlation of IL-6 and transforming growth factor-beta (TGF-β) with histological rejection. Clin Exp Immunol 1993;93:448-51
44. Blancho G, Moreau JF, Chabannes D, Chatenoud L, Soulillou JP. HILDA/LIF, G.CSF, IL-1b, IL-6, and TNFα production during acute rejection of human kidney allografts. Transplantation 1993;56:597-602
45. Nickerson P, Pacheco-Silva A, O'Connell PJ, Steurer W, Rubin Kelley V, Strom TB. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transpl Proc 1993;25:984-85
46. Yard BA, Kooymans-Couthino M, Paape ME, et al. Analysis of cytokine production by graft-infiltrating cells isolated from rejecting renal allografts. Transplantation 1994;57:153-55
47. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft: A sequential study. Transplantation 1994;57:1333-37
48. Sun J, McCaughan GW, Matsumoto Y, Sheil AGR, Gallagher ND, Bishop GA. Tolerance to rat liver allografts: I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994;57: 1349-57
49. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992;54:326-32
50. Krams SM, Falco DA, Villanueva JC. et al. Cytokine and T cell receptor gene expression at the site of allograft rejection, Inflam Immuno-Rhumat 1992;53:151-56
51. Nickerson P, Pacheco-Silva A, O'Connell PJ, Steurer W, Rubin Kelley V, Strom TB. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transpl Proc 1993;25:984-85
52. Steinmuller DR. FK506 and organ transplantation. Medical Intelligence Unit. R.G. Landes Co, Austin, Texas, USA 1994
53. Tocci MJ, Matkovich DA, Collier KA, et al. The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes. J Immunol 1989;143:718-26
54. Tzakis AG, Todo S, Reyes J, et al. Intestinal transplantation in children under FK 506 immunosuppression. J Pediatric Surgery 1993;28:1040-43
55. Reding R, Wallemacq PE, Lamy ME, et al. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts: Efficacy, toxicity, and dose regimen in 23 children. Transplantation 1994;57:93-100
56. Armitage JM, Fricker FJ, Starzl TE, Hardesty RL, Griffith BP. A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J Thorac Cardiovasc Surg 1993;105:464-73
57. Harris JB, Johnson MA, Karlsson E. Pathological responses of a rat skeletal muscle to a single subcutaneous injection of a toxin isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol 1975;2:383-404